The World Health Organization is in the midst of an agency search for a global campaign on antimicrobial resistance, the growing problem of infectious diseases adapting to modern antibiotics and similar drugs.
The American Board of Obstetrics and Gynecology is relying on outside PR support after the group said in the face of months of criticism this week that it lifted a ban on its members treating male patients.
Richard Sorian, a key Obama administration healthcare pro who recently tackled PR for Washington, D.C.'s health insurance exchange, has moved to FleishmanHillard to heads its health operation in the capital.
Filmmaker Michael Moore's New York Times op-ed critical of Obamacare appears to be little more than a publicity stunt, a way for the aging director to portray himself as a serious critic while keeping his name and face in front of the media.
Amy Schulman, SVP, general counsel and head of the $3.2 billion healthcare business at Pfizer, has suddenly agreed “by mutual agreement” to depart the company—a switch that is being billed as a firing by the pharmaceutical trade press.
Pfizer has ended the advertising portion of its “Get Old” campaign and switched to PR via Edelman although its building at 235 E. 42nd St. (between Second and Third Aves.) is decorated with large-size ads for the campaign.